Aperio Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Aperio Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,417	Closed	-$32K	–	2299
2018 Q1	$32K	Buy	17,417 +1,264	+8%	+$2.67K	﹤0.01%	2239
2017 Q4	$36K	Buy	+16,153	New	+$40.2K	﹤0.01%	2232
2017 Q3	–	Sell	-13,054	Closed	-$58K	–	2253
2017 Q2	$58K	Buy	13,054 +1,244	+11%	+$5.13K	﹤0.01%	2195
2017 Q1	$55K	Sell	11,810 -9,442	-44%	-$54.8K	﹤0.01%	2127
2016 Q4	$129K	Sell	21,252 -1,094	-5%	-$5.72K	﹤0.01%	2063
2016 Q3	$123K	Buy	22,346 +7,249	+48%	+$33.9K	﹤0.01%	2007
2016 Q2	$57K	Sell	15,097 -7,663	-34%	-$26K	﹤0.01%	1984
2016 Q1	$63K	Buy	22,760 +6,229	+38%	+$22.6K	﹤0.01%	1994
2015 Q4	$94K	Buy	16,531 +5,725	+53%	+$34.9K	﹤0.01%	1921
2015 Q3	$57K	Buy	+10,806	New	+$83.6K	﹤0.01%	1898

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Aperio Group's SGYP Position: Q2 2018 in Review

Aperio Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 17,417 shares — an estimated $32K sold.

Aperio Group first reported a position in SGYP in Q3 2015 and held it in 10 quarters. The position peaked at $129K in Q4 2016. 136 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

Aperio Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
Aperio Group sold 17,417 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $32K.
Aperio Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 10 quarters.
Aperio Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $129K in Q4 2016.
136 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on Aperio Group's 13F filing for Q2 2018, filed 30 Jul 2018.